A detailed history of Bromfield Sneider Wealth Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bromfield Sneider Wealth Advisors holds 280 shares of MRK stock, worth $28,526. This represents 0.02% of its overall portfolio holdings.

Number of Shares
280
Previous 280 -0.0%
Holding current value
$28,526
Previous $30,000 20.0%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 06, 2022

SELL
$83.49 - $94.64 $56,689 - $64,260
-679 Reduced 70.8%
280 $26,000
Q1 2022

Apr 12, 2022

BUY
$73.51 - $82.4 $70,496 - $79,021
959 New
959 $79,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bromfield Sneider Wealth Advisors Portfolio

Follow Bromfield Sneider Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bromfield Sneider Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bromfield Sneider Wealth Advisors with notifications on news.